Skip to main navigation
Telesis Bio Logo
    • Home
    • Products
      • Coronavirus
        • RNA controls
        • Synthetic genomes
        • Services
        • Resources
      • BioXp™ system
        • Gene synthesis
        • DNA cloning
        • Libraries
        • Resources
      • Benchtop reagents
        • Gibson assembly kits
        • RapidAMP kits
        • Vmax X2 cells
        • Resources
      • Services
        • Contact
    • Workflows
      • Research applications
        • Antibody drug discovery
        • Genome editing
        • Metabolic engineering
      • Clinical applications
        • Precision medicine
        • Vaccine development
        • Immune monitoring
        • Regenerative medicine
    • Innovation
      • SOLA Technology
    • About
      • Leadership
      • Careers
      • Press + news
      • Distributors
      • Events
      • Legal
      • Blog
    • Investors
      • News & Events
      • Stock Info
      • Corporate Governance
      • Financials & Filings
      • IR Resources
    • Order
    • Contact
  • Order
  • Support

Investor Relations

  • Investors
  • News + events
    • News Releases
    • Events
    • Presentations
  • Stock information
    • Stock Quote & Chart
    • Historic Price Lookup
    • Analyst Coverage
  • Corporate governance
    • Governance Overview
    • Board of Directors
    • Management
    • Committee Composition
  • Financials + filings
    • SEC Filings
    • Annual Reports & Proxies
    • Quarterly Results
  • IR resources
    • Investor FAQs
    • Email Alerts
    • Contact IR

SEC Filing Details

Financials and Filings Menu

Financials and Filings Menu

  • SEC Filings
  • |
  • Annual report + proxy
  • |
  • Quarterly Results

SEC Filing Details

Document Details

Form
10-Q
Filing Date
Nov 9, 2022
Document Date
Sep 30, 2022
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Telesis Bio
Issuer
TELESIS BIO INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
XML - XBRL INSTANCE DOCUMENT

About Telesis Bio

Telesis Bio Inc. is building biology. Creators of the BioXp® system, the world’s only fully automated gene synthesis platform, and the industry-standard Gibson Assembly® method, Telesis Bio Inc. is focused on enabling researchers with the tools they need to rapidly and securely design, code, and create synthetic DNA.

Telesis Bio Inc. is accelerating advances in the fields of personalized medicine, biologics drug discovery, vaccine development, genome editing, and cell and gene therapy.

Site

  • Products
  • Workflows
  • Support
  • About
  • Investors
  • Order
  • Contact

Links

  • Events
  • Blog
  • Careers
  • Terms of use
  • Cookie policy
  • Privacy policy
  • Legal

© 2023 Telesis Bio Inc. All rights reserved.

Telesis Bio Logo